ASHLEY AGURA: Open Payments
NPI 1871988519 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 53 payments from 16 companies in 2025. Trend: 2023 $1,792 · 2024 $1,467 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 9 | $322 |
| Insmed, Inc. | 7 | $180 |
| ABBVIE INC. | 6 | $140 |
| Paratek Pharmaceuticals, Inc. | 5 | $92 |
| Astellas Pharma US Inc | 4 | $89 |
| Theratechnologies Inc. | 4 | $85 |
| Ferring Pharmaceuticals Inc. | 3 | $77 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Shionogi Inc | 3 | $50 |
Products named: Arikayce, DOVATO, DALVANCE, NUZYRA, Cresemba, EGRIFTA, REBYOTA, PIFELTRO.
Industry payments across TX — which companies pay providers there.
